Astria Therapeutics

ATXS57

$12.35arrow_drop_up6.37%$0.74

ATXS57

$12.35

arrow_drop_up6.37%$0.74

Performance History

Key Stats
Open	$11.59
Prev. Close	$11.50
EPS	-2.38
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	11.31	12.01
52 Week Range	4.26	16.90

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.38

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Astria Therapeutics (ATXS)

Astria Therapeutics, Inc. (ATXS) is a biopharmaceutical company focused on the development of innovative therapies for various diseases. The company's stock price history has been relatively stable, with gradual growth over the years. Investors have shown a positive sentiment towards Astria Therapeutics, resulting in a steady increase in its stock price.

Astria Therapeutics is known for its dedication to research and development, constantly working on groundbreaking treatments that can potentially improve patients' lives. The company has a strong pipeline of drugs, with several candidates in various stages of clinical trials. This indicates that Astria Therapeutics is committed to bringing novel therapies to market.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Jill C. Milne Ph.D.
Headquarters: Boston
Employees: 45
Exchange: NASDAQ

Keep an eye on Astria Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Astria Therapeutics's (ATXS) price per share?

The current price per share for Astria Therapeutics (ATXS) is $12.35. The stock has seen a price change of $0.74 recently, indicating a 6.37% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Astria Therapeutics (ATXS)?

For Astria Therapeutics (ATXS), the 52-week high is $16.9, which is 36.84% from the current price. The 52-week low is $4.26, the current price is 189.91% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Astria Therapeutics (ATXS) a growth stock?

Astria Therapeutics (ATXS) has shown an average price growth of 0.41% over the past three years. It has received a score of 60 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Astria Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Astria Therapeutics (ATXS) stock price performance year to date (YTD)?

As of the latest data, Astria Therapeutics (ATXS) has a year-to-date price change of 58.54%. Over the past month, the stock has experienced a price change of 5.74%. Over the last three months, the change has been 37.37%. Over the past six months, the figure is -20.88%.

help

Is Astria Therapeutics (ATXS) a profitable company?

Astria Therapeutics (ATXS) has a net income of -$72.89M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$67.83M. Furthermore, the EBITDA is $0.

help

What is the market capitalization of Astria Therapeutics (ATXS)?

Astria Therapeutics (ATXS) has a market capitalization of $648.89M. The average daily trading volume is 266.36K, indicating the stock's liquidity and investor engagement.